Olifant Medical, Inc. SBIR Phase I Award, March 2022
A SBIR Phase I contract was awarded to Olifant Medical, Inc. in March, 2022 for $249,465.0 USD from the U.S. Department of Defense and Defense Health Agency.
Name
# Contributions
Last Contribution
Find more entities like Olifant Medical, Inc. SBIR Phase I Award, March 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
